Benchmark Maintains Buy on DexCom, Raises Price Target to $82

DexCom, Inc.

DexCom, Inc.

DXCM

0.00

Benchmark analyst Bruce D. Jackson maintains DexCom (NASDAQ: DXCM) with a Buy and raises the price target from $77 to $82.